BioSpace News Archive

Francis M. Smith, Esq. NJ Personal Injury Attorney explores the impact of new law

Pipeline Corner Presentation, Mini Oral Sessions and Paper Poster Session to take place April 22-23

SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using Human Dermal Fibroblasts, has filed an Investigational New Drug (IND) Application with the U.S. Food and Drug Administration (FDA) to expand its study of CybroCell Human Dermal Fibroblasts to treat degenerative disc disease.

The National Institute of Allergy and Infectious Diseases Radiation Nuclear Countermeasures Program awarded the contract

InControl Medical LLC, the world’s largest supplier of medical devices that treat/cure stress, urge and mixed bladder and bowel leakage in women and men, announced today a record sales increase of 191% first quarter 2018 versus the same period last year.

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2018 results on Tuesday, May 8, 2018.

ndd Medical Technologies, Inc., the leader in lung function testing, announced that Patti Peters, the long-term Vice President of Sales and Marketing, handed over the reins to Thomas Sinclair.

Charles River Laboratories International, Inc. will release first-quarter 2018 financial results on Thursday, May 10th, before the market opens.

Landmark five-year publication in Spine addresses important U.S. payer coverage obstacles for patients seeking single-level disc replacement

Revenues increased 21% to €7.69 million for the full year 2017 Net new business of €14.69 million, increased backlog by 23% to €23 million for the full year Cash and cash equivalents are €28.29 million, as of December 31, 2017